Plné znění - 2/2008 Sb. m. s.

Ministerstvo zahraničních xxxx sděluje, xx xxx 16. listopadu 2007 bylo xxxxxxxxxx xxxxxxxxx UNESCO, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx ve xxxxxx¹⁾, xxxxxxxx schválení xxxxxx xxxxx Přílohy I - Xxxxxxx zakázaných xxxxx x metod xxxxxxx.

Xxxxxxx X xxxxxxxxx x xxxxxxxx v xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. ledna 2008 x xxxxx xxxx vstoupila x xxxxxxxx x xxx Xxxxxx republiku. Dnem xxxxxx Xxxxxxx X x xxxxxxxx xxxxxxxx xxxxxx Příloha I Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx xx xxxxx pro xxx 2007, xxxxxxxxx xxx č. 59/2007 Xx. m. x.

Xxxxxxxx xxxxx Přílohy X x xxxx xxxxxxx xx xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-androst-1-en-3,17-dion); xxxxxxxxx (19-norandrostendiol); bolasteron; xxxxxxxx; xxxxxxx (androsta-1,4-dien-3,17-dion); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); dehydrochlormethyltestosteron (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); desoxymethyltestosteron (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-hydroxytestosteron (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxx; mesterolon; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-dimetyl-5α-androstan-3-on-17β-ol); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; norethandrolon; xxxxxxxxxxxx; xxxxxxxx; oxandrolon; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; xxxxxxxxxx; xxxxxxxxx; 1-testosteron (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); trenbolon x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

x. Xxxxxxxxx ** AAS:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), xxxxxxxxxxx x xxxxxxxxxxx xxxxxxxxxx x isomery:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-androstan-3β,17α-diol 5-androstendion (xxxxxxx-5-xx-3,17-xxxx)

5α-androstan-3β,17β-diol epi-dihydrotestosteron

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

androst-5-en-3α,17β-diol

X xxxxxxxxx, xxx xxxx xxxx produkovat androgenní xxxxxxxxxx xxxxxxx přirozeně, xxxx se xxx xx xx, že Xxxxxx xxxxxxxx tuto Xxxxxxxxx látku x xxxx xxxxxx pozitivní Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx se xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx metabolitů xxxx xxxxxxxxxxx x/xxxx xxxx xx xxxxxxxx xxxx xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx u xxxx tak, xx xxxxxxxxxx xxxxxxxx endogenní xxxxxxxx. Nebude xx xxx za to, xx Xxxxxx obsahuje Xxxxxxxxx látku x xxxxxxx případě, xxxxx Xxxxxxxxx prokáže, xx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx xxxxxxxxx poměr xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxx.

Bude xx xxx xx xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Xxxxxxxxx laboratorní xxxxx xx xxxxx xxxxxxxxx a při xxxxxxxxx xxxxxxxxxxx, pokud xxx xxxxx spolehlivé xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx, že xx Zakázaná xxxxx xxxxxxxxxx xxxxxx. V xxxxxxx případě není xxxxx xxxxxxxx další xxxxxxx.

Když xx xxxxxxx xxxxxxxx analýzy xxxxxxxx xxxxxxxxxxx xx xxxxxxx hodnot, xxxxx xx xxxxxxxx vyskytují x lidí x xxxxx xxxxxxxxxx analytická xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx, xxxx xxxx. xxxxxxxxx x xxxxxxxxxxx referenčními xxxxxxxxxxx xxxxxxx, xxxx xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X vyšší než xxxxx (4) xx xxxxx (1) x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx původ xxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx organizace další xxxxxxx porovnáním xxxxxxxx xxxxxxxxxx testů xxxx xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx xxxxxxxxxx takové xxxxx šetření, xxx xxxxxxxx xxxx xxxxxxxxxx xxxxxx xxxx xxxxxxxxx x xx jako xxxxxxxxx. Pokud xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx nutné xxxxxxxx xxxxx xxxxxxx, x xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx. Pokud nebyla xxxxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. XXXX) x xxxxxx k xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx testy, bude xxxxxxx longitudinální profil Xxxxxxxxx tím, xx xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxx 3 xxxxxxxx xxxxxxx xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Výsledek, xxxxx xxxxxxxxxx xxxx longitudinální xxxxxx, xxxx xxxxxx xxxx neobvyklý. Pokud xxxxxxxxxxxxxx xxxxxx Sportovce, xxxxxxxx xxxxxxxxxx xxxxx, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx xx pak xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx xxxxx.

V xxxxxxxx xxxxxxxx individuálních xxxxxxxxx xxxx xxx x xxxx xxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx ve velice xxxxxx xxxxxxxxxxxxx (xx/xx). Xxxxx laboratoř xxxxxx xxxxx xxxxxxxxx x xxxxxxx spolehlivé xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx látky, xxxx xxx provedeno další xxxxxxx provedením xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx laboratoř xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx 19-xxxxxxxxxxxxxxx, bude se xx xxxxxxxxx za xxxxxxx a xxxxxxxxxxx xxxxx xxxxxxxxxx původu Xxxxxxxx xxxxx. X xxxxxxx případě xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

X xxxxxxx, xx Xxxxxxxxx nebude xxxxxxxxxxxxx při xxxxxxx xxxxxxxxx, xxxx se xxx za to, xx Vzorek Xxxxxxxxx xxxxxxxx Xxxxxxxxx látku.

2. Xxxxxxx xxxxxxxxxx xxxxx, xxxxxxxxxx:

Klenbuterol, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SARM), tibolon, xxxxxxx, xxxxxxxxxx, ale xx s omezením xxxxx na ně.

S2. XXXXXXX A XXXXXXXX XXXXX

Xxxxxxxxxxx xxxxx x jejich xxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxxxx (XXX);

2. Růstový hormon (xXX), insulinu xxxxxxx xxxxxxx xxxxxxx (xxxx. XXX-1), xxxxxxxxxx xxxxxxx xxxxxxx (MGF);

3. Xxxxxxxxxxxxx (např. LH, xXX), xxxxxxxx xxx x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x další látky x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Pokud Xxxxxxxxx xxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx stavem, bude xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx látku (xxx xx uvedeno xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Zakázané xxxxx xxxx xxxxxx xxxxxxxxxx xx xxxxxxxxxx x/xxxx xxxxxxxxx xxxxxx xx Vzorku Xxxxxxxxx xxxxxxx xxxxxxxx hodnoty xxxxxxxx xxxxxxxx x xxxx xxx, xx xxxxxxxxxxxx normální xxxxxxxxx xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, xx xxxxx xxxxxxxxxx analytické metody, xx Xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxx, xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx Zakázanou xxxxx x xxxx xxxxxxx Xxxxxxxxx laboratorní xxxxx.

S3. XXXX-2 XXXXXXXX

Xxxxxxx xxxx-2 agonisté xxxxxx xxxxxx D- x X-xxxxxxx xxxx zakázáni.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, xxx které xx při inhalaci xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxx.

X xxxx byla xxxxxxx xxxxxxxx forma xxxxxxxxxxxx xxxxxxx, xxxx nález xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx než 1000 xxxxxxxxx x 1 mililitru xxxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxxxx, že xxxxxxxxxx xxxxxxxx byl xxxxxxxx terapeutickým xxxxxxxx xxxxxxxxxxx x xxxxxxxx.

S4. XXXXXXXXXXX X MODULÁTORY XXXXXXX

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Inhibitory xxxxxxxx, zahrnující:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SERM), xxxxxxxx:

3. Xxxxxxx antiestrogenní látky xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx funkce xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx xx x omezením xxxxx xx xx.

X5. XXXXXXXXX X XXXXXXX XXXXXXXXX LÁTKY

Xxxxxxxxx látky xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, xxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, dutasterid), plasmaexpandery (xxxx. albumin, xxxxxxx, xxxxxxxxxxxxxxxxx) a xxxxx xxxxx x podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxx, amilorid, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, spironolakton, xxxxxxxx (např. bendroflumethiazid, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky (kromě xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx xxxx xxxxxx, xxxxx moč Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx x xxxxxxxx xxxx xxxxxxxxxxx xxxxxxxx xxxx Xxxxxxxx látky (xxxxx).

X1. ZVYŠOVÁNÍ XXXXXXX XXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

X2. CHEMICKÁ X XXXXXXXXX XXXXXXXXXX

X3. XXXXXX DOPING

Xxxxxxxxxxxxxx xxxxxxx buněk, genů, xxxxxxxx elementů, xxxx xxxxxxxxxx exprese xxxx, xxxxx xxxx xxxxxxxxx xxxxxx sportovní výkon, xx zakázané.

X6. XXXXXXXXXXX

Všechna xxxxxxxxxxx (xxxxxx obou xxxxxx xxxxxxxxxx xxxxxxxxx (X- x L-) xxxxxxx) jsou xxxxxxxx, x xxxxxxxx derivátů xxxxxxxxx v xxxxxxx xxxxxx xxxxxxxx užití x xxxxxxxxxxx xxxxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx xxx xxx 2008.

Xxxxxxxxxxx xxxxxxxx:

Adrafinil, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, fenkamin, xxxxxxxxxxx, fenprometamin, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, heptaminol, isomethepten, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, mefentermin, meklofenoxát, xxxxxxxxxxxx (X-), metylefedrin****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, modafinil, niketamid, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx x další látky x podobnou xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx xxxxxxxx x xxxxx xxxxxx bude xxxxxxxxxx xx specifickou xxxxx xxxxx, pokud Xxxxxxxxx xxxxxxx, xx xxxx všeobecná xxxxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx je x xxx xxxxx xxxxxxxxxxxxxxx, xx bude xxxxxxx xxxxxxxx xxxx dopingová xxxxx.

X7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), fentanyl x xxxx xxxxxxxx, xxxxxxxxxxx, xxxxxxx, morfin, xxxxxxxx, oxymorfon, pentazocin, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, marihuana) xxxx xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Všechny xxxxxxxxxxxxxxxxxxxx xxxxxxxx orálně, xxxxxxxx, xxxxxxxxxx nebo xxxxxxxxxxxxx xxxxxxxx jsou xxxxxxxx. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx výjimku.

Xxxx xxxxxxx injekční aplikace (xxxxxxxxxxxx, do xxxxx xxxxxx, xx xxxxx xxxxxx, epidurální, xx xxxx) x inhalační xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxx xxxxxxxxx.

Xxxxxxx přípravky xxxxxxxx xx potíže xxxxx (xxxxxx iontoforézy/fonoforézy), ušní, xxxxx, xxxx, potíže xxxxx xxxxxxx xxxxxx, xxxxxxxx úst x xxxxx nejsou zakázané x xxxxxxxxxx xxxxxx xxxxx xxxxxxxxxxxx xxxxxxx.

P1. XXXXXXX

Xxxxxxx (xxxxxx) xx xxxxxxxx xxxxx Xxx xxxxxxx v xxxxxxxxxxxxx sportech. Detekce xx xxxx provádět xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Xxxxxxx xxxxxxx xxx porušení xxxxxxxxxxx pravidla (hematologická xxxxxxx) je xxx xxxxxx federaci xxxxxxx x závorkách.

∙ Xxxxxxxxxxxx sport (XXX) (0.10 x/x)

∙ Xxxxxx (WKF) (0.10 x/x)

∙ Xxxxxxx xxxxxx a xxxxxxxxxxxx (XXX) (0.20 g/l)

∙ Xxxxxxxxxxx (FITA, XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxxx (XXXX) jen pro xxxxxxxxxx se xxxxxxxx (0.10 g/l)

∙ Xxxxxxxxxxx sport (XXX) (0.10 x/x)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 x/x)

∙ Kuželky (XXX) (0.10 x/x)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx jinak určeno, xxxx-xxxxxxxxx jsou zakázány xxxxx Xxx xxxxxxx x následujících xxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Xxxx (XXXX)

∙ Bridž (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Xxxxxxx xxxxxx a parašutismus (XXX)

∙ Lukostřelba (XXXX, XXX) (xxxxxxxx xxxx Xxxx soutěž)

∙ Xxxxxxxx (FIS) - skoky xx xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx a X-xxxxx, x xxxxxxxxx U-rampa x "xxx xxx"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx xx střelbou

∙ Motocyklový xxxxx (XXX)

∙ Xxxxxxxx x obdobné xxxxxx (XXXX, XXX "bowls")

∙ Xxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx soutěž)

∙ Xxxxx xxxxxxxxxx (UIM)

∙ Xxxxx (FILA)

Xxxx-xxxxxxxxx zahrnují xxxxxxxxxxx xxxxx:

Acebutolol, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, metipranolol, metoprolol, xxxxxxx, xxxxxxxxxx, pindolol, xxxxxxxxxxx, xxxxxxx, timolol, xxx xx x xxxxxxxx pouze xx xx

"Specifické látky"* xxxx xxxxxxxxxxx níže:

∙ Všichni Beta-2 xxxxxxxx x inhalaci, xxxxx salbutamolu (xxxxxxx xxxx xxxxxxxxxxx) xxx xxxxxxxx větším xxx 1000 ng/ml xxxx x xxxxxxxxxxxx (xxxxxxx xx xxxxxxx S 1.2 Xxxxxxx anabolické xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, probenecid;

∙ Xxxxx, xxxxxxxxxxx, krotetamid, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, meklofenoxát, p-metylamfetamin, xxxxxxxxxxxx, xxxxxxxxx, norfenefrin, xxxxxxxxx, ortetamin, oxilofrin, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx x oddíle X6, pro xxxxx Xxxxxxxxx xxxxxxx, xx xxxxxxx podmínky popsané x xxxxxx S6;

∙ Kanabinoidy;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"V Seznamu xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, xxxxx xxxxxxxx umožňuji xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx xxxx xxxxxxxxx xxxxxxxx v xxxxxxx xxxxxxxxx xxxxxxxxxxx, nebo x xxxxx xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx úspěšně xxxxxxxx xxxx xxxxxxxxx činidla." Xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx xx xxxxxxxxxxx, xx "...Sportovec xxxx xxxxx prokázat, že Xxxxxxx specifické látky xxxxxx zamýšleno xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Sb. x. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Xx. m. x. xxx xxxxxx xxxxxxx předpisem č. 8/2009 Sb. m. s. x účinností xx 7.2.2009.

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx právních xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx netýká xxxxxxxxx xxxxx xxxxx uvedeného xxxxxxxx xxxxxxxx.